Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more
Ekso Bionics Holdings Inc (EKSO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.480x
Based on the latest financial reports, Ekso Bionics Holdings Inc (EKSO) has a cash flow conversion efficiency ratio of -0.480x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.33 Million) by net assets ($9.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ekso Bionics Holdings Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Ekso Bionics Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ekso Bionics Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ekso Bionics Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JMC Electronics Co Ltd
TW:6552
|
0.030x |
|
NicOx S.A.
PA:ALCOX
|
-0.002x |
|
EcoFirst Consolidated Bhd
KLSE:3557
|
0.008x |
|
PVP Ventures Limited
NSE:PVP
|
0.006x |
|
ACHILLES THERAP.SP.ADS/1
F:698
|
N/A |
|
Broncus Holding Corporation
PINK:BRNHF
|
-0.029x |
|
Sono-Tek Corp
NASDAQ:SOTK
|
0.063x |
|
Mahkota Group Tbk PT
JK:MGRO
|
-0.440x |
Annual Cash Flow Conversion Efficiency for Ekso Bionics Holdings Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Ekso Bionics Holdings Inc from 2012 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.03 Million | $-11.80 Million | -1.307x | -68.72% |
| 2024-12-31 | $12.71 Million | $-9.85 Million | -0.775x | +18.97% |
| 2023-12-31 | $12.61 Million | $-12.05 Million | -0.956x | -65.63% |
| 2022-12-31 | $25.44 Million | $-14.69 Million | -0.577x | -92.61% |
| 2021-12-31 | $37.22 Million | $-11.16 Million | -0.300x | +84.82% |
| 2020-12-31 | $4.43 Million | $-8.76 Million | -1.975x | +14.91% |
| 2019-12-31 | $6.80 Million | $-15.77 Million | -2.320x | +71.44% |
| 2018-12-31 | $2.73 Million | $-22.16 Million | -8.125x | -456.59% |
| 2017-12-31 | $21.39 Million | $-31.23 Million | -1.460x | +61.86% |
| 2016-12-31 | $6.53 Million | $-25.00 Million | -3.827x | -84.53% |
| 2015-12-31 | $8.81 Million | $-18.27 Million | -2.074x | -215.12% |
| 2014-12-31 | $22.80 Million | $-15.01 Million | -0.658x | +17.39% |
| 2013-12-31 | $15.05K | $-11.99K | -0.797x | 0.00% |
| 2012-12-31 | $15.05K | $-11.99K | -0.797x | -- |